Skip to main content

Brookdale Senior Living Inc. (BKD)

Sector
Health Care
Last price
$9.98
As of

Kresmion compiles this page from BKD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Brookdale Senior Living Inc. (BKD): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-08.

As of . Source: SEC EDGAR filings for BKD. Method and limitations.

COMPANY DOSSIER

See the full BKD dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for BKD on one page. Preview it with sample data, then open it live with a free account.

Preview the BKD dossier

Active events for BKD

  • mediumEarnings above estimates

    Q2-2026: Beat consensus by 278.3%, EPS $0.10 vs $-0.0561 estimate

  • mediumEarnings below estimates

    Q3-2025: Missed consensus by 16.3% - EPS $-0.2 vs $-0.172 estimate

  • mediumEarnings below estimates

    Q2-2025: Missed consensus by 30.5% - EPS $-0.18 vs $-0.1379 estimate

  • mediumEarnings below estimates

    Missed consensus by 16.3% - EPS $-0.2 vs $-0.172 estimate

  • lowEarnings below estimates

    Q1-2026: EPS $-0.03 vs $-0.0222 estimate, -0.01 on a near-zero consensus

FREE, NO ACCOUNT

Every event on BKD, as it fires

New filings, 13F moves and cross asset events on BKD land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in BKD (2026Q2)

Manager / securityMarket value% portfolioQoQ
TWO SIGMA INVESTMENTS, LPCUSIP 112463104 · 2026Q2$109.4M0.08%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 112463104 · 2026Q2$95.8M0.13%,
MILLENNIUM MANAGEMENT LLCCUSIP 112463104 · 2026Q2$70.6M0.03%,
D. E. Shaw & Co., Inc.CUSIP 112463104 · 2026Q2$68.2M0.03%,
CITADEL ADVISORS LLCCUSIP 112463104 · 2026Q2$16.6M0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, BKD

BKD against its peers

BKD's operating margin of 0.4% ranks in the 40th percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.

MetricBKDPeer medianPercentilen
Revenue FY3.2B USD1.2B USD8325
Gross margin26.2%54.6%1318
Operating margin0.4%5.0%4023
Net margin-8.2%1.1%2125
Return on equityn/a1.5%n/a25
P / En/a38.1xn/a13

Peers (25): MD, TMDX, PGNY, ACHC, INSP, SEM.D, PRVA, AVAH, WGS, LMAT, XRAY, ATRC, AMN, ATEC, CERT, ALHC, NVCR, OMCL, NVST, PNTG, IRTC, CRVL, CNMD, TNDM, ITGR. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (BKD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Follow BKD on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to BKD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the BKD dossier
Share

The BKD intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.